Alexium continues to see forward momentum in both revenue and gross profit from increased order volume with existing customers and new customers coming on line. Chemistry sales grew over 1000% to $11,193,372 for the period, an increase from $973,121 from the previous half year report, from core product sales. The group’s net loss for the period, $5,806,993, down from $9,008,753 for the half-year ended 31 December 2015, is related to increased sales revenue and improved margins on customer orders.
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.10M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $2.087K | 298.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1210906 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.04pm 18/07/2025 (20 minute delay) ? |
| AJX (ASX) Chart |